Analysis and Commentary STEVEN GROSSMAN 3/22/19 Analysis and Commentary STEVEN GROSSMAN 3/22/19 Sorting Out the Details of the President's FY 20 Request Read More Analysis and Commentary STEVEN GROSSMAN 8/4/17 Analysis and Commentary STEVEN GROSSMAN 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More Analysis and Commentary STEVEN GROSSMAN 7/21/17 Analysis and Commentary STEVEN GROSSMAN 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More Analysis and Commentary STEVEN GROSSMAN 5/12/17 Analysis and Commentary STEVEN GROSSMAN 5/12/17 Proposed FDA FY 18 Budget Swap a Non-Starter Read More Advocacy at a Glance STEVEN GROSSMAN 5/12/17 Advocacy at a Glance STEVEN GROSSMAN 5/12/17 President’s Full Budget Release Set for May 23 and more Read More Analysis and Commentary STEVEN GROSSMAN 12/16/16 Analysis and Commentary STEVEN GROSSMAN 12/16/16 Time for a Deep Breath Before the New Year Begins Read More
Analysis and Commentary STEVEN GROSSMAN 3/22/19 Analysis and Commentary STEVEN GROSSMAN 3/22/19 Sorting Out the Details of the President's FY 20 Request Read More
Analysis and Commentary STEVEN GROSSMAN 8/4/17 Analysis and Commentary STEVEN GROSSMAN 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More
Analysis and Commentary STEVEN GROSSMAN 7/21/17 Analysis and Commentary STEVEN GROSSMAN 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More
Analysis and Commentary STEVEN GROSSMAN 5/12/17 Analysis and Commentary STEVEN GROSSMAN 5/12/17 Proposed FDA FY 18 Budget Swap a Non-Starter Read More
Advocacy at a Glance STEVEN GROSSMAN 5/12/17 Advocacy at a Glance STEVEN GROSSMAN 5/12/17 President’s Full Budget Release Set for May 23 and more Read More
Analysis and Commentary STEVEN GROSSMAN 12/16/16 Analysis and Commentary STEVEN GROSSMAN 12/16/16 Time for a Deep Breath Before the New Year Begins Read More
